[Inf 295] week 6 parul seth patient-reported outcomes as a source of evidence in off-label prescribing
Impact of Exploratory Analysis on Drug Approval Joga Gobburu Pharmacometrics Office Clinical Pharmacology, CDER, FDA [email protected].
Utilizing the powerful impact of real-time information on drug development and new product launch
zidovudine hplc method
Alzheimers Disease Strategies
Cryosurgery and Electrosurgery Adam O. Goldstein, MD Associate Professor UNC Dept Family Medicine Chapel Hill, NC [email protected].
WHAT IS A BIOSTATISTICIAN TRYING TO PROVE? PROOF IN MEDICAL RESEARCH
1 Who Needs Bayesian Phase I Trials? Rick Chappell Professor, Departments of Statistics and of Biostatistics and Medical Informatics University of Wisconsin.
Fall 2003